Viral and host mediators of non-suppressible HIV-1 viremia
Abbas Mohammadi,Behzad Etemad,Xin Zhang,Yijia Li,Gregory J Bedwell,Radwa Sharaf,Autumn Kittilson,Meghan Melberg,Charles R Crain,Anna K Traunbauer,Colline Wong,Jesse Fajnzylber,Daniel P Worrall,Alex Rosenthal,Hannah Jordan,Nikolaus Jilg,Clarety Kaseke,Francoise Giguel,Xiaodong Lian,Rinki Deo,Elisabeth Gillespie,Rida Chishti,Sara Abrha,Taylor Adams,Abigail Siagian,Dominic Dorazio,Peter L Anderson,Steven G Deeks,Michael M Lederman,Sigal Yawetz,Daniel R Kuritzkes,Mathias D Lichterfeld,Scott Sieg,Athe Tsibris,Mary Carrington,Zabrina L Brumme,Jose R Castillo-Mancilla,Alan N Engelman,Gaurav D Gaiha,Jonathan Z Li
DOI: https://doi.org/10.1038/s41591-023-02611-1
Abstract:Non-suppressible HIV-1 viremia (NSV) is defined as persistent low-level viremia on antiretroviral therapy (ART) without evidence of ART non-adherence or significant drug resistance. Unraveling the mechanisms behind NSV would broaden our understanding of HIV-1 persistence. Here we analyzed plasma virus sequences in eight ART-treated individuals with NSV (88% male) and show that they are composed of large clones without evidence of viral evolution over time in those with longitudinal samples. We defined proviruses that match plasma HIV-1 RNA sequences as 'producer proviruses', and those that did not as 'non-producer proviruses'. Non-suppressible viremia arose from expanded clones of producer proviruses that were significantly larger than the genome-intact proviral reservoir of ART-suppressed individuals. Integration sites of producer proviruses were enriched in proximity to the activating H3K36me3 epigenetic mark. CD4+ T cells from participants with NSV demonstrated upregulation of anti-apoptotic genes and downregulation of pro-apoptotic and type I/II interferon-related pathways. Furthermore, participants with NSV showed significantly lower HIV-specific CD8+ T cell responses compared with untreated viremic controllers with similar viral loads. We identified potential critical host and viral mediators of NSV that may represent targets to disrupt HIV-1 persistence.